Takeda Pharmaceutical Company Limited

TSE:4502 Stok Raporu

Piyasa değeri: JP¥6.5t

Takeda Pharmaceutical Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Takeda Pharmaceutical şirketinin toplam hissedar öz sermayesi ¥6,921.6B ve toplam borcu ¥5,051.2B olup, bu da borç-öz sermaye oranını 73% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥14,573.0B ve ¥7,651.4B dir. Takeda Pharmaceutical 'in FAVÖK'ü ¥653.6B faiz karşılama oranı 6.7 dur. Şirketin ¥859.0B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

73.0%

Borç/özkaynak oranı

JP¥5.05t

Borç

Faiz karşılama oranı6.7x
NakitJP¥859.02b
EşitlikJP¥6.92t
Toplam yükümlülüklerJP¥7.65t
Toplam varlıklarJP¥14.57t

Son finansal sağlık güncellemeleri

Recent updates

Here's Why Takeda Pharmaceutical (TSE:4502) Can Manage Its Debt Responsibly

Nov 25
Here's Why Takeda Pharmaceutical (TSE:4502) Can Manage Its Debt Responsibly

Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 04
Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Sep 24
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Sep 20
Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Aug 08
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 02
Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Jul 25
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Jul 11
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Jun 30
Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Jun 11
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

May 21
Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

May 12
Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Mar 28
Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Mar 13
Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Feb 26
Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 4502 'nin kısa vadeli varlıkları ( ¥3,054.0B ) kısa vadeli yükümlülüklerini ( ¥2,387.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: 4502 'un kısa vadeli varlıkları ( ¥3,054.0B ) uzun vadeli yükümlülüklerini ( ¥5,264.2B ) karşılamamaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 4502 'nin net borç/öz sermaye oranı ( 60.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 4502 'nin borç/öz sermaye oranı son 5 yılda 103.2% seviyesinden 73% seviyesine düştü.

Borç Kapsamı: 4502 'nin borcu işletme nakit akışı ( 17.3% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 4502 'in borcuna ilişkin faiz ödemeleri EBIT ( 6.7 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin